Botulinum toxin in wound treatment – literature review
DOI:
https://doi.org/10.12775/JEHS.2024.68.49876Keywords
botulinum toxin, wounds, scars, hypertrophic scars, skin ulcersAbstract
Introduction and purpose
Botulinum toxin has been used in medicine since the 1970s, although many years earlier it was known only as a biological weapon. Originally, it was used in medicine to treat strabismus in children. Over time, it has been used in the treatment of neurological disorders, excessive sweating of the armpits, wrinkles, and bladder disorders. In recent years, botulinum toxin has also begun to be used in wound healing. The paralyzing effect of botulinum toxin on the muscles within the wound eliminates micro-injuries caused by tension in these muscles. The aim of the article is to summarize information on the effects of botulinum toxin on the wound, its impact on inflammation, and the type of scar formation.
Materials and methods
The literature included in the PubMed databases is searched through the words such as botulinum toxin, wounds, and scars.
Description of the state of knowledge:
The literature review shows the breadth of the issue. Scientific studies showing the effect of using botulinum toxin on wounds emphasize its beneficial effects. However, it should be remembered that wound healing has a complex, dynamic course supported by numerous cellular processes that must be closely coordinated to effectively repair damaged tissues. Determinants influencing the course of wound healing include both local and systemic factors. Important factors influencing the process of proper wound healing are specialized wound preparation, pharmacotherapy, and other aspects of therapeutic intervention.
Conclusions
The range of applications of botulinum toxin is constantly expanding. In addition to reducing muscle tension within the wound, it also inhibits the production of inflammatory transmitters, limiting its development, and also reduces the development of microcirculation by preventing the development of vessels in hypertrophic scars.
References
Anandan Ch, Jankovic J. Botulinum Toxin in Movement Disorders: An Update. Toxins (Basel). 2021 Jan; 13(1): 42. doi: 10.3390/toxins13010042. PMID: 33430071. PMCID: PMC7827923.
Dressler D, Johnson EA. Botulinum toxin therapy: past, present and future developments. J Neural Transm (Vienna).2022; 129(5-6): 829–833. doi: 10.1007/s00702-022-02494-5, PMID: 35396965. PMCID: PMC9188496.
Park JH, Park HJ. Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins (Basel). 2017 Sep; 9(9): 260. doi: 10.3390/toxins9090260. PMID: 28837075. PMCID: PMC5618193.
Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs. 2021; 81(18): 2091–2101. doi: 10.1007/s40265-021-01631-w. PMID: 34787840. PMCID: PMC8648634.
Freeman MD, Margulies IG, Sanati-Mehrizy P, Burish N, Taub PJ. Nonaesthetic Applications for Botulinum Toxin in Plastic Surgery. Plast Reconstr Surg. 2020 Jul;146(1):157-170. doi: 10.1097/PRS.0000000000006908. PMID: 32590660.
Dhawan A, Dhawan S, Vitarella D. The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review. J Drugs Dermatol. 2018 Sep 1;17(9):956-958. PMID: 30235381.
Wang YX, Wang Y, Zhang Q, Zhang RD. Current Research of Botulinum Toxin Type A in Prevention and Treatment on Pathological Scars. Dermatol Surg. 2023 May 1;49(5S):S34-S40. doi: 10.1097/DSS.0000000000003770. PMID: 37115998.
Park J, Chung ME. Botulinum Toxin for Central Neuropathic Pain. Toxins (Basel). 2018 Jun; 10(6): 224. doi: 10.3390/toxins10060224. PMID: 29857568. PMCID: PMC6024683.
Matak I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 2014 Aug-Sep:119-120:39-59. doi: 10.1016/j.pneurobio.2014.06.001. PMID: 24915026.
Evans DM, Williams RS, Shone CC, Hambleton P, Melling J, Dolly JO. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem. 1986 Jan 15;154(2):409-16. doi: 10.1111/j.1432-1033.1986.tb09413.x. PMID: 3753681.
Grenda T, Grenda A, Krawczyk P, Kwiatek K. Botulinum toxin in cancer therapy—current perspectives and limitations. Appl Microbiol Biotechnol. 2022; 106(2): 485–495. doi: 10.1007/s00253-021-11741-w. PMID: 34951660. PMCID: PMC8763801.
Castiglione A, Bagnato S, Boccagni C, Romano MC, Galardi G. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain. Arch Phys Med Rehabil. 2011 Jul;92(7):1034-7. doi: 10.1016/j.apmr.2011.01.015. PMID: 21704782.
Al-Qattan MM, Al-Shanawani BN, Alshomer F. Botulinum toxin type A: implications in wound healing, facial cutaneous scarring, and cleft lip repair. Ann Saudi Med. 2013 Sep-Oct; 33(5): 482–488. doi: 10.5144/0256-4947.2013.482. PMID: 24188943. PMCID: PMC6074896.
Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol. 2012 Jun;15(3):325-36. doi: 10.1016/j.mib.2012.05.012. PMID: 22770659.
Wang PH, Huang BS, Horng HC, Yeh CC, Chen YJ. Wound healing.J Chin Med Assoc. 2018 Feb;81(2):94-101. doi: 10.1016/j.jcma.2017.11.002. PMID: 29169897.
Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020 Sep; 10(9): 200223. doi: 10.1098/rsob.200223. PMID: 32993416. PMCID: PMC7536089.
Schlessinger J, Gilbert E, Cohen JL, Kaufman J. New Uses of AbobotulinumtoxinA in Aesthetics. Aesthet Surg J. 2017 May; 37(Suppl 1): S45–S58. doi: 10.1093/asj/sjx005. PMID: 28388720. PMCID: PMC5434494.
Gouin JP, Kiecolt-Glaser JK. The Impact of Psychological Stress on Wound Healing: Methods and Mechanisms. Immunol Allergy Clin North Am. Immunol Allergy Clin North Am. 2011 Feb; 31(1): 81–93. doi: 10.1016/j.iac.2010.09.010. PMID: 21094925. PMCID: PMC3052954.
Han G, Ceilley R. Chronic Wound Healing: A Review of Current Management and Treatments. Adv Ther. 2017; 34(3): 599–610. doi: 10.1007/s12325-017-0478-y. PMID: 28108895. PMCID: PMC5350204.
Guo X, Song G, Zhang D, Jin X. Efficacy of Botulinum Toxin Type A in Improving Scar Quality and Wound Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aesthet Surg J. 2020 Apr 14;40(5):NP273-NP285. doi: 10.1093/asj/sjz165. PMID: 31155638.
Kucukkaya D, Irkoren S, Ozkan S, Sivioglu N. The effects of botulinum toxin A on the wound and skin graft contraction. J Craniofac Surg. 2014 Sep;25(5):1908-11. doi: 10.1097/SCS.0000000000000941. PMID: 25102391.
Zhou N, Li D, Luo Y, Li J, Wang Y. Effects of Botulinum Toxin Type A on Microvessels in Hypertrophic Scar Models on Rabbit Ears. Biomed Res Int. 2020; 2020: 2170750. doi: 10.1155/2020/2170750. PMID: 32626735. PMCID: PMC7315252.
Oryana A, Alemzadeh E. Comparison of botulinum toxin type A and aprotinin monotherapy with combination therapy in healing of burn wounds in an animal model. Mol Biol Rep. 2020 Apr;47(4):2693-2702. doi:10.1007/s11033-020-05367-w. PMID: 32146683.
Gassner HG, Sherris DA, Otley CC. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg. 2000 May;105(6):1948-53; discussion 1954-5. doi: 10.1097/00006534-200005000-00005. PMID: 10839391.
Ziade M, Domergue S, Batifol D, Jreige R, Sebbane M, Goudot P, Yachouh J. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. J Plast Reconstr Aesthet Surg. 2013 Feb;66(2):209-14. doi: 10.1016/j.bjps.2012.09.012. PMID: 23102873.
Kim SH, Lee SJ, Lee JW, Jeong HS, Suh IS. Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study. Medicine (Baltimore). 2019 Aug;98(34):e16952. doi: 10.1097/MD.0000000000016952. PMID: 31441893. PMCID: PMC6716761.
Huang YI, Wallace CG, Hsiao YC, Lee MC, Huang JJ, Chang FCS, Chen ZC, Hu S, Chen JP. Botulinum Toxin to Improve Lower Blepharoplasty Scar: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial. Aesthet Surg J. 2021 Aug 13;41(9):1003-1010. doi: 10.1093/asj/sjab024. PMID: 34128526.
Disphanurat W, Viarasilpa W, Thienpaitoon P. Efficacy of Botulinum Toxin A for Scar Prevention After Breast Augmentation: A Randomized Double-Blind Intraindividual Controlled Trial. Dermatol Surg. 2021 Dec 1;47(12):1573-1578. doi: 10.1097/DSS.0000000000003198. PMID: 34818273.
Li YH, Yang J, Liu JQ, Xie ST, Zhang YJ, Zhang W, Zhang JL, Zheng Z, Hu DH. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound. Aesthetic Plast Surg. 2018 Oct;42(5):1364-1369. doi: 10.1007/s00266-018-1187-x. PMID: 30019241.
Phillips TJ, Fung E, Rigby MH, Burke E, Hart RD, Trites JRB, Gassner HG, Taylor SM. The Use of Botulinum Toxin Type A in the Healing of Thyroidectomy Wounds: A Randomized, Prospective, Placebo-Controlled Study. Plast Reconstr Surg. 2019 Feb;143(2):375e-381e. doi: 10.1097/PRS.0000000000005264. PMID: 30688903.
Chen S, Yang Y, Zhang D, Liu Y, Li Y. Local Injection of Botulinum Toxin Type A to Prevent Postoperative Scar. J Craniofac Surg. 2020 Mar/Apr;31(2):440-443. doi: 10.1097/SCS.0000000000006144. PMID: 31977704.
Flynn TC. Use of intraoperative botulinum toxin in facial reconstruction. Dermatol Surg. 2009 Feb;35(2):182-8. doi: 10.1111/j.1524-4725.2008.34407.x. PMID: 19215253.
Sonane J, Sharma RK, John JR, Sharma R. Botulinum Toxin for a Better Scar in Cleft Lip Surgery: A Prospective Randomized Control Trial. J Craniofac Surg. 2022 Jan-Feb;33(1):198-202. doi: 10.1097/SCS.0000000000007836. PMID: 34267122.
Chang CS, Wallace CG, Hsiao YC, Chang CJ, Chen KT. Botulinum toxin to improve results in cleft lip repair. Plast Reconstr Surg. 2014 Sep;134(3):511-516. doi: 10.1097/PRS.0000000000000416. PMID: 25158709.
Zhong J, Lan Y, Fu S, Zhang J, Lu S, He Y, Zhang JM. Botulinum Toxin A Injection for Treatment of Chronic Skin Ulcer: A Case Series and Literature Review. Int J Low Extrem Wounds. 2019 Mar;18(1):97-103. doi: 10.1177/1534734618816589. PMID: 30696317.
Winayanuwattikun W, Vachiramon V. Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article. Toxins (Basel). 2022 Jun; 14(6): 406. doi: 10.3390/toxins14060406. PMID: 35737067. PMCID: PMC9230442
Shenavandeh S, Sepaskhah M, Dehghani S, Nazarinia MA. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis. Clin Rheumatol. 2022 Jan;41(1):95-104. doi: 10.1007/s10067-021-05900-7. PMID: 34471968. PMCID: PMC8409478.
Liu L, Xue Y, Chen Y, Chen T, Zhong J, Shao X, Chen J.Prevalence and risk factors of acne scars in patients with acne vulgaris. Skin Res Technol. 2023 Jun;29(6):e13386. doi: 10.1111/srt.13386. PMID: 37357642. PMCID: PMC10240192.
Amer A, Elhariry S, Al-Balat W. Combined autologous platelet-rich plasma with microneedling versus microneedling with non-cross-linked hyaluronic acid in the treatment of atrophic acne scars: Split-face study. Dermatol Ther. 2021 Jan;34(1):e14457. doi: 10.1111/dth.14457. PMID: 33107665.
Ibrahim AM, Omar GAB, Hamdino M. Long-pulsed Nd: YAG laser (1064 nm) versus intralesional botulinum toxin type (A) in acne vulgaris therapy: a split face study. Int J Dermatol. 2023 Jun;62(6):822-830. doi: 10.1111/ijd.16519. PMID: 36468835.
Berman B, Maderal A, Raphael B. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment. Dermatol Surg. 2017 Jan:43 Suppl 1:S3-S18. doi: 10.1097/DSS.0000000000000819. PMID: 27347634.
Xiao Z, Zhang F, Lin W, Zhang M, Liu Y. Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: a preliminary report. Aesthetic Plast Su. 2010 Aug;34(4):424-7. doi: 10.1007/s00266-009-9423-z. PMID: 19802513.
Elshahed AR, Elmanzalawy KS, Shehata H, ElSaie ML. Effect of botulinum toxin type A for treating hypertrophic scars: A split-scar, double-blind randomized controlled trial. J Cosmet Dermatol. 2020 Sep;19(9):2252-2258. doi: 10.1111/jocd.13627. PMID: 32668499.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aneta Jerzak, Aleksandra Janocha, Anna Hitnarowicz, Bożena Kmak, Anna Szot, Agnieszka Pociecha
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 215
Number of citations: 0